Skip to content

Effects of Combined Heat Application and Acupressure to the Carotid Artery Region on Cerebral Blood Flow in Healthy Adults

Effects of Combined Heat Application and Acupressure to the Carotid Artery Region on Cerebral Blood Flow in Healthy Adults: An Investigator-Initiated, Single-Group, Single-Center, Prospective Case Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07324226
Enrollment
9
Registered
2026-01-07
Start date
2026-02-01
Completion date
2026-12-31
Last updated
2026-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Subjects/Volunteers

Keywords

Carotid artery, Heat application, SPECT imaging, Acupressure Combined heat and acupressure, Cerebral blood flow, Single-group prospective study, Single-center study

Brief summary

The aim of this study is to investigate the effects of combined heat application and acupressure to the carotid artery region on cerebral blood flow in healthy adults

Interventions

DEVICECombined heat and acupressure

Press the start button to activate the automatic mode. When the start button is pressed, the device operates for approximately 40 minutes. When the start button is pressed, acupressure massage is performed with a single back-and-forth cycle from acupressure bar No. 1 to No. 18. The device then performs back-and-forth acupressure massage between acupressure bars No. 18 and No. 13 for the remaining time. After operating for 40 minutes in automatic mode, the mattress heating unit, the acupressure bar heating unit, and the acupressure bar movement are all turned off. 1. Press the shoulder button. The acupressure bar operates in the neck-to-shoulder section (acupressure bars No. 1 to 6), and both the mattress heating unit and the acupressure bar heating unit are activated. 2. After operating for 20 minutes in manual mode, the mattress heating unit, the acupressure bar heating unit, and the acupressure bar movement are turned off.

Sponsors

Pusan National University Yangsan Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults aged 40 to 65 years. * Individuals with no history of cerebrovascular, cardiovascular, or neurological diseases. * Individuals who have signed the informed consent form and voluntarily agreed to participate in the study

Exclusion criteria

* Individuals with a history of cerebrovascular, cardiovascular, or neurological diseases (e.g., stroke, angina, epilepsy). Individuals currently taking medications that may affect cerebral blood flow (such as antihypertensive agents or antidepressants). Individuals with skin diseases or lesions that make it difficult to apply heat or acupressure devices to the carotid artery region, and individuals who are pregnant or breastfeeding. Individuals with a history of seizures. Individuals who have participated in clinical studies two or more times in the same year, or who have participated in another clinical study within the past 6 months. Individuals who, in the judgment of the principal investigator or sub-investigator, have clinically significant findings that make them unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frameDescription
A SPECT CT brain scanIn the post-SPECT protocol, the radiopharmaceutical will be administered at 5 minutes (n=3), 10 minutes (n=3), and 20 minutes (n=3) after the start of image acquisition.Cerebral blood flow change rate analysis: For each participant, the percentage change in cerebral blood flow (CBF) observed on SPECT imaging compared with the baseline time point will be quantitatively analyzed at the following three time points. Radiopharmaceutical injection reference times: 5 minutes, 10 minutes, and 20 minutes after injection.

Countries

South Korea

Contacts

Primary ContactJisoo Baik, Doctoral
zisoo@pusan.ac.kr82+055-360-4159

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026